2026 Q3 Portfolio Activity
In 2026 Q3, Nantahala Capital Management, LLC maintained a portfolio of 188 distinct positions. The most significant new addition was SPDR SERIES TRUST, now representing 2.20% of the total fund value. They heavily accumulated shares in BANCORP INC DEL, increasing the position by 1064.8%. The fund also reduced its exposure to ISHARES TR by 98.3%.
Position History
hover any row below to update
Loading…
Total Positions
188
Quarter
2026 Q3
Top Holding
IWM (15.8%)
Top 10 Concentration
37.4%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-50 of 188
Nantahala Capital Management, LLC Full Holdings List — 2026 Q3
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
IWM
PUT
ISHARES TR
|
PUT Option | 15.82% | 20.00% |
#1
Prev: #1
|
6.5 |
—
|
-200,000 | -10.0% |
P
S
|
1,800,000 | $500,202,000 |
$166.62
+61.5%
|
2012 Q1 | 13F Filing | 2026-09-30 | 2026-11-13 | ||
|
XBI
PUT
SPDR SERIES TRU...
|
PUT Option | 3.49% | 2.11% |
#2
5
Prev: #7
|
5.9 |
—
|
300,000 | 75.0% |
P
S
|
700,000 | $110,376,000 |
$92.96
+56.3%
|
2014 Q2 | 13F Filing | 2026-09-30 | 2026-11-13 | ||
|
VTRS
CALL
VIATRIS INC
|
CALL Option | 2.80% | 2.64% |
#3
1
Prev: #4
|
3.1 |
—
|
no change | no change |
P
S
|
5,000,000 | $88,600,000 |
$8.53
+229.6%
|
2025 Q2 | 13F Filing | 2026-09-30 | 2026-11-13 | ||
|
BVS
BIOVENTUS INC
|
Healthcare | 2.77% | 1.89% |
#4
4
Prev: #8
|
3.6 |
—
|
420,605 | 7.0% |
P
S
|
6,420,884 | $87,516,649 | 2022 Q3 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
PTON
CALL
PELOTON INTERAC...
|
CALL Option | 2.69% | 3.23% |
#5
3
Prev: #2
|
2.1 |
—
|
634,900 | 3.9% |
P
S
|
17,073,800 | $85,198,262 | 2020 Q1 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
TBBK
BANCORP INC DEL
|
Financial Services | 2.23% | 2.59% |
#6
1
Prev: #5
|
2.9 |
—
|
225,390 | 18.2% |
P
S
|
1,465,277 | $70,567,740 | 2014 Q2 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
KRE
PUT
SPDR SERIES TRU...
|
PUT Option | 2.20% | — |
#7
Prev: #—
|
4.4 |
—
|
1,000,000 | — |
NEW
|
1,000,000 | $69,440,000 | 2016 Q4 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
EW
PUT
EDWARDS LIFESCI...
|
PUT Option | 2.18% | 2.41% |
#8
2
Prev: #6
|
1.9 |
—
|
no change | no change |
P
S
|
800,000 | $69,056,000 | 2025 Q3 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
HLF
CALL
HERBALIFE LTD
|
CALL Option | 1.65% | 2.89% |
#9
6
Prev: #3
|
0.7 |
—
|
-2,295,200 | -34.8% |
P
S
|
4,304,800 | $52,217,224 | 2012 Q2 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
EOLS
EVOLUS INC
|
Healthcare | 1.58% | 1.29% |
#10
4
Prev: #14
|
2.6 |
—
|
642,669 | 11.5% |
P
S
|
6,244,690 | $49,957,520 | 2023 Q3 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
PTON
PELOTON INTERAC...
|
Consumer Cyclical | 1.43% | 1.01% |
#11
13
Prev: #24
|
3.6 |
—
|
3,935,440 | 77.0% |
P
S
|
9,044,435 | $45,131,731 | 2020 Q1 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
ETON
ETON PHARMACEUT...
|
Healthcare | 1.43% | 1.42% |
#12
Prev: #12
|
0.6 |
—
|
-300,444 | -25.5% |
P
S
|
875,507 | $45,079,855 | 2024 Q2 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
HGV
HILTON GRAND VA...
|
Consumer Cyclical | 1.40% | 1.80% |
#13
3
Prev: #10
|
3.1 |
—
|
243,372 | 23.6% |
P
S
|
1,276,542 | $44,244,946 | 2022 Q4 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
AMRX
AMNEAL PHARMACE...
|
Healthcare | 1.35% | 1.31% |
#14
1
Prev: #13
|
1.0 |
—
|
-153,002 | -6.7% |
P
S
|
2,115,749 | $42,611,185 | 2023 Q1 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
LBRX
LB PHARMACEUTIC...
|
Healthcare | 1.30% | 1.14% |
#15
3
Prev: #18
|
1.0 |
—
|
21,480 | 2.0% |
P
S
|
1,074,374 | $41,234,474 | 2025 Q3 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
PRAX
PUT
PRAXIS PRECISIO...
|
PUT Option | 1.29% | 1.11% |
#16
4
Prev: #20
|
3.0 |
—
|
40,300 | 40.3% |
P
S
|
140,300 | $40,859,569 | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
HGV
CALL
HILTON GRAND VA...
|
CALL Option | 1.29% | 1.87% |
#17
8
Prev: #9
|
2.5 |
—
|
99,500 | 9.3% |
P
S
|
1,174,500 | $40,708,170 | 2022 Q4 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
RARE
CALL
ULTRAGENYX PHAR...
|
CALL Option | 1.19% | — |
#18
Prev: #—
|
4.0 |
—
|
2,500,000 | — |
NEW
|
2,500,000 | $37,575,000 | 2026 Q3 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
SVRA
SAVARA INC
|
Healthcare | 1.16% | 1.43% |
#19
8
Prev: #11
|
1.0 |
—
|
160,349 | 2.3% |
P
S
|
7,137,159 | $36,827,740 | 2023 Q3 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
FOSL
FOSSIL GROUP IN...
|
Consumer Cyclical | 1.14% | 0.76% |
#20
14
Prev: #34
|
1.5 |
—
|
no change | no change |
P
S
|
5,505,128 | $36,168,691 | 2023 Q2 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
RARE
ULTRAGENYX PHAR...
|
Healthcare | 1.11% | — |
#21
Prev: #—
|
3.9 |
—
|
2,339,293 | — |
NEW
|
2,339,293 | $35,159,574 | 2026 Q3 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
QTUM
PUT
ETF SER SOLUTIO...
|
PUT Option | 1.07% | 1.23% |
#22
7
Prev: #15
|
1.4 |
—
|
no change | no change |
P
S
|
223,000 | $33,811,260 | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
AVTX
AVALO THERAPEUT...
|
Healthcare | 1.04% | 1.15% |
#23
6
Prev: #17
|
2.4 |
—
|
280,058 | 15.0% |
P
S
|
2,142,308 | $32,841,582 | 2025 Q1 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
MDXG
MIMEDX GROUP IN...
|
Healthcare | 1.02% | 0.61% |
#24
23
Prev: #47
|
2.9 |
—
|
2,143,012 | 44.9% |
P
S
|
6,910,564 | $32,203,228 | 2022 Q4 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
NBIX
CALL
NEUROCRINE BIOS...
|
CALL Option | 0.99% | 1.12% |
#25
6
Prev: #19
|
2.4 |
—
|
20,400 | 10.2% |
P
S
|
220,400 | $31,261,536 | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
IMAX
CALL
IMAX CORP
|
CALL Option | 0.95% | — |
#26
Prev: #—
|
3.9 |
—
|
550,000 | — |
NEW
|
550,000 | $30,140,000 | 2020 Q4 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
DLB
CALL
DOLBY LABORATOR...
|
CALL Option | 0.93% | — |
#27
Prev: #—
|
3.9 |
—
|
500,000 | — |
NEW
|
500,000 | $29,385,000 | 2011 Q4 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
ABEO
ABEONA THERAPEU...
|
Healthcare | 0.90% | 1.06% |
#28
6
Prev: #22
|
2.4 |
—
|
274,153 | 5.3% |
P
S
|
5,410,643 | $28,405,875 | 2022 Q4 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
ESTA
ESTABLISHMENT L...
|
Healthcare | 0.89% | 0.96% |
#29
4
Prev: #25
|
2.9 |
—
|
104,726 | 31.2% |
P
S
|
440,556 | $28,270,479 | 2018 Q3 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
KRYS
PUT
KRYSTAL BIOTECH...
|
PUT Option | 0.89% | 1.05% |
#30
7
Prev: #23
|
1.4 |
—
|
no change | no change |
P
S
|
85,000 | $28,267,600 | 2024 Q2 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
DKS
CALL
DICKS SPORTING ...
|
CALL Option | 0.85% | — |
#31
Prev: #—
|
3.8 |
—
|
200,000 | — |
NEW
|
200,000 | $26,858,000 | 2025 Q2 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
TITN
TITAN MACHY INC
|
Industrials | 0.83% | 0.80% |
#32
Prev: #32
|
0.8 |
—
|
4,501 | 0.4% |
P
S
|
1,137,589 | $26,255,554 | 2024 Q3 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
ADMA
ADMA BIOLOGICS ...
|
Healthcare | 0.82% | 0.66% |
#33
11
Prev: #44
|
2.3 |
—
|
230,482 | 9.8% |
P
S
|
2,590,475 | $25,982,464 | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
SNAP
CALL
SNAP INC
|
CALL Option | 0.82% | 0.71% |
#34
4
Prev: #38
|
1.3 |
—
|
no change | no change |
P
S
|
4,800,000 | $25,920,000 | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
FOXF
FOX FACTORY HLD...
|
Consumer Cyclical | 0.82% | 0.74% |
#35
Prev: #35
|
2.3 |
—
|
92,889 | 7.1% |
P
S
|
1,403,584 | $25,783,838 | 2024 Q4 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
DSGR
DISTRIBUTION SO...
|
Industrials | 0.81% | 0.45% |
#36
27
Prev: #63
|
2.8 |
—
|
239,103 | 48.3% |
P
S
|
733,684 | $25,605,572 | 2025 Q2 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
FULC
FULCRUM THERAPE...
|
Healthcare | 0.77% | 0.67% |
#37
5
Prev: #42
|
2.8 |
—
|
1,100,312 | 20.1% |
P
S
|
6,575,352 | $24,328,802 | 2022 Q4 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
XTNT
XTANT MED HLDGS...
|
Healthcare | 0.77% | 0.96% |
#38
12
Prev: #26
|
1.3 |
—
|
no change | no change |
P
S
|
68,394,000 | $24,286,710 | 2023 Q3 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
GOGO
GOGO INC
|
Communication Services | 0.76% | 0.90% |
#39
11
Prev: #28
|
2.8 |
—
|
2,517,061 | 28.9% |
P
S
|
11,214,792 | $24,111,803 | 2022 Q2 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
AURA
AURA BIOSCIENCE...
|
Healthcare | 0.76% | 0.70% |
#40
Prev: #40
|
2.8 |
—
|
856,270 | 29.0% |
P
S
|
3,807,300 | $23,909,844 | 2021 Q4 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
REGN
REGENERON PHARM...
|
Healthcare | 0.75% | — |
#41
Prev: #—
|
3.8 |
—
|
31,141 | — |
NEW
|
31,141 | $23,613,286 | 2025 Q3 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
JACK
JACK IN THE BOX...
|
Consumer Cyclical | 0.72% | 0.91% |
#42
15
Prev: #27
|
0.8 |
—
|
2,000 | 0.1% |
P
S
|
1,730,659 | $22,879,312 | 2012 Q1 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
RMR
RMR GROUP INC
|
Real Estate | 0.72% | 0.78% |
#43
10
Prev: #33
|
2.3 |
—
|
104,925 | 9.1% |
P
S
|
1,252,827 | $22,651,112 | 2020 Q4 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
HLF
HERBALIFE LTD
|
Consumer Defensive | 0.71% | 0.49% |
#44
15
Prev: #59
|
3.3 |
—
|
738,011 | 66.5% |
P
S
|
1,847,165 | $22,406,111 | 2012 Q2 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
IRD
OPUS GENETICS I...
|
Healthcare | 0.70% | 0.42% |
#45
23
Prev: #68
|
2.8 |
—
|
1,508,169 | 49.3% |
P
S
|
4,569,528 | $22,116,516 | 2025 Q1 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
ZVRA
ZEVRA THERAPEUT...
|
Healthcare | 0.68% | 0.86% |
#46
16
Prev: #30
|
2.3 |
—
|
165,620 | 9.2% |
P
S
|
1,963,096 | $21,535,164 | 2023 Q3 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
AVR
ANTERIS TECHNOL...
|
Healthcare | 0.68% | 1.11% |
#47
26
Prev: #21
|
0.8 |
—
|
-623,528 | -18.4% |
P
S
|
2,759,807 | $21,443,700 | 2024 Q4 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
INSP
INSPIRE MED SYS...
|
Healthcare | 0.64% | 0.40% |
#48
24
Prev: #72
|
2.3 |
—
|
23,560 | 8.7% |
P
S
|
293,034 | $20,324,838 | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
ABVX
ABIVAX SA
|
Healthcare | 0.62% | 0.59% |
#49
1
Prev: #48
|
2.7 |
—
|
64,986 | 48.6% |
P
S
|
198,745 | $19,679,730 | 2023 Q4 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
AGMB
AGOMAB THERAPEU...
|
Healthcare | 0.61% | 0.68% |
#50
9
Prev: #41
|
2.2 |
—
|
179,582 | 11.5% |
P
S
|
1,747,770 | $19,400,247 | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-13 |
Showing 1-50 of 188 holdings